Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Trial Of The Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy Symptoms In Subjects With Advanced Colorectal Cancer.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 12 Feb 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 06 Jun 2010 Results have been presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
- 12 May 2009 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
- 24 Sep 2008 Actual patient number (63) added as reported by CT.gov